CRISPR, APGAR and Cancer Screening: Public Engagement, Controversy and Misaligned Values
{{output}}
There are many calls for public engagement in decision-making around controversial technologies, but far fewer calls for public engagement in deliberation around less controversial interventions. We think the public should be involved in discussing CRISPR, but... ...